Dow Jones Top Company Headlines at 3 AM ET: ASML Narrows Guidance Amid Tariff Uncertainty, Warns on 2026 Growth | Cartier ...

Dow Jones
Jul 16

ASML Narrows Guidance Amid Tariff Uncertainty, Warns on 2026 Growth

The chip-making equipment supplier, whose U.S. clients include Intel, issued the warning days after President Trump's threat of 30% tariffs against the European Union.

----

Cartier Parent Richemont Posts Sales Growth Despite Luxury Slowdown

The luxury group's jewelry division, which houses heavyweight brands Cartier and Van Cleef & Arpels, saw an 11% rise in sales.

----

Stellantis Scraps Hydrogen Vehicle Program

The Jeep parent said it would discontinue its hydrogen fuel-cell technology development program because it doesn't expect its adoption in light commercial vehicles before the end of the decade.

----

Rio Tinto's Iron Ore Output Highest Since 2018; Flags Tariff Costs

The world's second-biggest miner by market value flagged around $300 million of gross costs from U.S. tariffs on its Canadian aluminum exports.

----

Alibaba-Backed Chinese AI Startup Files for Hong Kong IPO

MiniMax has confidentially filed for an initial public offering in Hong Kong, according to people familiar with the matter, signaling the onset of a race among China's generative AI startups to tap public markets.

----

Trump Touts Billions in Investments to Create AI Hub in Pennsylvania

The commitments are part of a campaign to transform the Steel City and surrounding areas.

----

CVS Beats Out UnitedHealth for Calpers Pharmacy Benefits Deal

CVS Health's Caremark business signed a new pharmacy benefits contract with the California Public Employees' Retirement System, known as Calpers.

----

Renault Cuts Guidance in Tough Auto Market, Names Interim CEO

Renault slashed its financial targets for the year, citing a worsening automotive market as the group faces stiff competition from rivals, and elevated finance chief Duncan Minto to interim CEO.

----

J.B. Hunt Profit Falls Due to Higher Expenses

J.B. Hunt Transport Services logged lower earnings in the second quarter as medical expenses, insurance costs and driver wages rose.

----

Omnicom Posts Lower Earnings Amid Interpublic Acquisition

Omnicom reported a lower profit for the second quarter, citing increased costs from its acquisition of rival Interpublic Group and severance actions stemming from efficiency initiatives.

----

Platinum Equity's LifeScan Files for Bankruptcy to Cut Debt, Cede Control to Lenders

The glucose-monitor maker will reduce more than 75% of its $1.7 billion in debt.

----

Aquarian Nears Deal for U.S. Insurer Brighthouse

A number of private-equity firms had expressed interest in the insurer.

----

Lilly's Zepbound Faces a Potential Weight-Loss Rival. It's Made by a Chinese Biotech.

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring to U.S. biopharma.

----

Newmont Stock Slides Sharply After Financial Chief Resigns

The Colorado-based gold miner is beginning the search for a permanent chief financial officer.

 

(END) Dow Jones Newswires

July 16, 2025 03:00 ET (07:00 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10